for the development of new health-care products??? and ???not[e], however, that this incentive alone does not meet the need for the development of new products to fight diseases where the potential paying market is small or uncertain[.]??? This clearly refers to diseases for which little research has been conducted and to those which disproportionately affect developing countries, such as AIDS or